Reported value$29.0M250,000 shares at $115.94
For this personNormal for them3 buys · 0 sales on file
Similar buys beat S&P46%170 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 11%.
- Their past buys: 5 of 6 beat the S&P 500 over 90 days.
Reasons for caution
- Similar past buys beat the S&P 500 only 46% of the time (170 cases); the typical one trailed it by 1.9%.
What happened after this filing
7 days
Pending
due Nov 3
30 days
Pending
due Nov 26
90 days
Pending
due Jan 25
Insider Twins: past buys with the same traits
2 insiders buying · no CEO or CFO · $1M+ · stock down 0–20% in 3 months
FUBO Oct 14, 2020 +282.1% vs S&PGTE Dec 22, 2025 +120.5% vs S&PMGNX Sep 11, 2023 +57.7% vs S&PMIST Jan 13, 2020 -71.2% vs S&PLYEL Mar 9, 2026 -62.1% vs S&PFULC Dec 29, 2022 -61.7% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Mitchell Jacobson (a director) bought $29M of MSM at about $115.94 on Oct 23, 2026, reported to the SEC on Oct 27, 2026. Buys like this beat the S&P 500 46% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the MSM alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.